President signs JOBS bill
This article was originally published in The Tan Sheet
Executive Summary
Multinational pharma, dietary supplement and nutritional product manufacturers will pay a reduced tax rate for repatriated foreign earnings after President Bush signed the legislation into law on Oct. 22. The bill cuts the repatriation tax rate from 35% to 5.25%, giving firms an incentive to repatriate earnings in the U.S. (1"The Tan Sheet" Oct. 18, 2004, p. 7). In an Oct. 29 earnings call, Schering-Plough CFO Bob Bertolini called the legislation "a very positive development" that will provide added financial flexibility, but noted it is "too early" to speculate how much of the firm's $9 bil. in undistributed foreign earnings will be repatriated...
You may also be interested in...
Pharma Firms Ready To Repatriate Billions Once “JOBS” Bill Is Signed
J&J intends to repatriate as much as $10 bil. held by foreign subsidiaries following President Bush's expected signing of the "JOBS" bill
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.